Literature DB >> 19116776

Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice.

Elizabeth P Newberry1, Susan M Kennedy, Yan Xie, Jianyang Luo, Nicholas O Davidson.   

Abstract

Liver fatty acid binding protein (L-FABP) is highly expressed in both enterocytes and hepatocytes and binds multiple ligands, including saturated (SFA), unsaturated fatty acids (PUFA), and cholesterol. L-fabp (-/-) mice were protected against obesity and hepatic steatosis on a high saturated fat (SF), high cholesterol "Western" diet and manifested a similar phenotype when fed with a high SF, low cholesterol diet. There were no significant differences in fecal fat content or food consumption between the genotypes, and fatty acid (FA) oxidation was reduced, rather than increased, in SF-fed L-fabp (-/-) mice as evidenced by decreased heat production and serum ketones. In contrast to mice fed with a SF diet, L-fabp (-/-) mice fed with a high PUFA diet were not protected against obesity and hepatic steatosis. These observations together suggest that L-fabp (-/-) mice exhibit a specific defect in the metabolism of SFA, possibly reflecting altered kinetics of FA utilization. In support of this possibility, microarray analysis of muscle from Western diet-fed mice revealed alterations in genes regulating glucose uptake and FA synthesis. In addition, intestinal cholesterol absorption was decreased in L-fabp (-/-) mice. On the other hand, and in striking contrast to other reports, female L-fabp (-/-) mice fed with low fat, high cholesterol diets gained slightly less weight than control mice, with minor reductions in hepatic triglyceride content. Together these data indicate a role for L-FABP in intestinal trafficking of both SFA and cholesterol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116776      PMCID: PMC3004673          DOI: 10.1007/s11010-008-0002-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Genetic analysis of intestinal cholesterol absorption in inbred mice.

Authors:  M Schwarz; D L Davis; B R Vick; D W Russell
Journal:  J Lipid Res       Date:  2001-11       Impact factor: 5.922

2.  Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice.

Authors:  D Q Wang; B Paigen; M C Carey
Journal:  J Lipid Res       Date:  2001-11       Impact factor: 5.922

3.  Distribution of body weight, blood insulin and lipid levels in the SMXA recombinant inbred strains and the QTL analysis.

Authors:  R V Anunciado; T Ohno; M Mori; A Ishikawa; S Tanaka; F Horio; M Nishimura; T Namikawa
Journal:  Exp Anim       Date:  2000-07

4.  Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene.

Authors:  Gregory G Martin; Heike Danneberg; Leena S Kumar; Barbara P Atshaves; Erdal Erol; Michael Bader; Friedhelm Schroeder; Bert Binas
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

5.  C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle.

Authors:  Gail Penner; Gyu Gang; Xiaoyan Sun; Curtis Wray; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

6.  Variability of the intestinal uptake of lipids is genetically determined in mice.

Authors:  M Keelan; D Y Hui; G Wild; M T Clandinin; A B Thomson
Journal:  Lipids       Date:  2000-08       Impact factor: 1.880

7.  Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains.

Authors:  B A Taylor; C Wnek; D Schroeder; S J Phillips
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

8.  Ablation of the liver fatty acid binding protein gene decreases fatty acyl CoA binding capacity and alters fatty acyl CoA pool distribution in mouse liver.

Authors:  Gregory G Martin; Huan Huang; Barbara P Atshaves; Bert Binas; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2003-10-07       Impact factor: 3.162

9.  Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation.

Authors:  Elizabeth P Newberry; Susan M Kennedy; Yan Xie; Britni T Sternard; Jianyang Luo; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-21       Impact factor: 4.052

10.  Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene.

Authors:  Elizabeth P Newberry; Yan Xie; Susan Kennedy; Xianlin Han; Kimberly K Buhman; Jianyang Luo; Richard W Gross; Nicholas O Davidson
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

View more
  24 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP.

Authors:  Na Gao; Xia Qu; Jin Yan; Qi Huang; Hao-Yong Yuan; Dong-Sheng Ouyang
Journal:  Mol Cell Biochem       Date:  2010-08-20       Impact factor: 3.396

3.  Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.

Authors:  Angela M Gajda; Yin Xiu Zhou; Luis B Agellon; Susan K Fried; Sarala Kodukula; Walter Fortson; Khamoshi Patel; Judith Storch
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

4.  Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.

Authors:  Jianguo Lin; Shizhong Zheng; Alan D Attie; Mark P Keller; David A Bernlohr; William S Blaner; Elizabeth P Newberry; Nicholas O Davidson; Anping Chen
Journal:  J Lipid Res       Date:  2018-01-09       Impact factor: 5.922

5.  Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Gregory J Gores
Journal:  Clin Lipidol       Date:  2010-02-01

Review 6.  Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.

Authors:  Angela M Gajda; Judith Storch
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-14       Impact factor: 4.006

7.  Muscle metabolic reprogramming underlies the resistance of liver fatty acid-binding protein (LFABP)-null mice to high-fat feeding-induced decline in exercise capacity.

Authors:  Heli Xu; Angela M Gajda; Yin Xiu Zhou; Cristina Panetta; Zoe Sifnakis; Anam Fatima; Gregory C Henderson; Judith Storch
Journal:  J Biol Chem       Date:  2019-08-26       Impact factor: 5.157

8.  CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells.

Authors:  Geneviève Mailhot; Rémi Rabasa-Lhoret; Alain Moreau; Yves Berthiaume; Emile Levy
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

9.  Phenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers.

Authors:  Elizabeth P Newberry; Susan Kennedy; Yan Xie; Jianyang Luo; Hui Jiang; Daniel S Ory; Nicholas O Davidson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

10.  Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.

Authors:  Anping Chen; Youcai Tang; Victoria Davis; Fong-Fu Hsu; Susan M Kennedy; Haowei Song; John Turk; Elizabeth M Brunt; Elizabeth P Newberry; Nicholas O Davidson
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.